nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenylpyraline—Doxapram—Fosphenytoin—epilepsy syndrome	0.119	0.138	CrCrCtD
Diphenylpyraline—Doxapram—Phenytoin—epilepsy syndrome	0.0816	0.0943	CrCrCtD
Diphenylpyraline—Phenindamine—Oxcarbazepine—epilepsy syndrome	0.0731	0.0844	CrCrCtD
Diphenylpyraline—Cyproheptadine—Carbamazepine—epilepsy syndrome	0.0686	0.0792	CrCrCtD
Diphenylpyraline—Modafinil—Fosphenytoin—epilepsy syndrome	0.0637	0.0735	CrCrCtD
Diphenylpyraline—Mianserin—Oxcarbazepine—epilepsy syndrome	0.0632	0.0729	CrCrCtD
Diphenylpyraline—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0444	0.0512	CrCrCtD
Diphenylpyraline—Modafinil—Phenytoin—epilepsy syndrome	0.0436	0.0504	CrCrCtD
Diphenylpyraline—Chlorcyclizine—Clobazam—epilepsy syndrome	0.0414	0.0478	CrCrCtD
Diphenylpyraline—Modafinil—Carbamazepine—epilepsy syndrome	0.0403	0.0465	CrCrCtD
Diphenylpyraline—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0371	0.0429	CrCrCtD
Diphenylpyraline—Methdilazine—Carbamazepine—epilepsy syndrome	0.0362	0.0418	CrCrCtD
Diphenylpyraline—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.0334	0.0385	CrCrCtD
Diphenylpyraline—Benzphetamine—Phenytoin—epilepsy syndrome	0.0328	0.0379	CrCrCtD
Diphenylpyraline—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0304	0.0351	CrCrCtD
Diphenylpyraline—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0291	0.0336	CrCrCtD
Diphenylpyraline—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0281	0.0324	CrCrCtD
Diphenylpyraline—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00675	0.223	CbGeAlD
Diphenylpyraline—SLC6A3—ganglion—epilepsy syndrome	0.0042	0.139	CbGeAlD
Diphenylpyraline—SLC6A3—hindbrain—epilepsy syndrome	0.00318	0.105	CbGeAlD
Diphenylpyraline—SLC6A3—brainstem—epilepsy syndrome	0.00183	0.0604	CbGeAlD
Diphenylpyraline—SLC6A3—forebrain—epilepsy syndrome	0.00176	0.0583	CbGeAlD
Diphenylpyraline—SLC6A3—telencephalon—epilepsy syndrome	0.00162	0.0536	CbGeAlD
Diphenylpyraline—SLC6A3—midbrain—epilepsy syndrome	0.00116	0.0385	CbGeAlD
Diphenylpyraline—SLC6A3—spinal cord—epilepsy syndrome	0.00114	0.0376	CbGeAlD
Diphenylpyraline—HRH1—forebrain—epilepsy syndrome	0.00102	0.0338	CbGeAlD
Diphenylpyraline—SLC6A3—head—epilepsy syndrome	0.00101	0.0334	CbGeAlD
Diphenylpyraline—SLC6A3—nervous system—epilepsy syndrome	0.000956	0.0316	CbGeAlD
Diphenylpyraline—HRH1—telencephalon—epilepsy syndrome	0.000941	0.0311	CbGeAlD
Diphenylpyraline—SLC6A3—central nervous system—epilepsy syndrome	0.000921	0.0305	CbGeAlD
Diphenylpyraline—SLC6A3—cerebellum—epilepsy syndrome	0.0009	0.0298	CbGeAlD
Diphenylpyraline—Doxapram—KCNK9—epilepsy syndrome	0.000892	0.0878	CrCbGaD
Diphenylpyraline—Doxapram—KCNK3—epilepsy syndrome	0.000892	0.0878	CrCbGaD
Diphenylpyraline—SLC6A3—brain—epilepsy syndrome	0.000731	0.0242	CbGeAlD
Diphenylpyraline—HRH1—head—epilepsy syndrome	0.000586	0.0194	CbGeAlD
Diphenylpyraline—HRH1—nervous system—epilepsy syndrome	0.000555	0.0184	CbGeAlD
Diphenylpyraline—HRH1—central nervous system—epilepsy syndrome	0.000535	0.0177	CbGeAlD
Diphenylpyraline—HRH1—brain—epilepsy syndrome	0.000424	0.014	CbGeAlD
Diphenylpyraline—Bepridil—CACNA2D2—epilepsy syndrome	0.000375	0.0369	CrCbGaD
Diphenylpyraline—Diphemanil Methylsulfate—CHRM3—epilepsy syndrome	0.000367	0.0362	CrCbGaD
Diphenylpyraline—Bepridil—CACNA1A—epilepsy syndrome	0.000355	0.035	CrCbGaD
Diphenylpyraline—Diphemanil Methylsulfate—CHRM1—epilepsy syndrome	0.000343	0.0337	CrCbGaD
Diphenylpyraline—Ifenprodil—GRIN2B—epilepsy syndrome	0.000259	0.0255	CrCbGaD
Diphenylpyraline—Dimenhydrinate—CHRM2—epilepsy syndrome	0.000253	0.0249	CrCbGaD
Diphenylpyraline—Clidinium—CHRM3—epilepsy syndrome	0.000241	0.0238	CrCbGaD
Diphenylpyraline—Trospium—CHRM3—epilepsy syndrome	0.000232	0.0229	CrCbGaD
Diphenylpyraline—Clidinium—CHRM1—epilepsy syndrome	0.000225	0.0222	CrCbGaD
Diphenylpyraline—Cinnarizine—CACNA1G—epilepsy syndrome	0.000224	0.0221	CrCbGaD
Diphenylpyraline—Bepridil—CACNA1H—epilepsy syndrome	0.000222	0.0218	CrCbGaD
Diphenylpyraline—Trospium—CHRM1—epilepsy syndrome	0.000217	0.0213	CrCbGaD
Diphenylpyraline—Bepridil—CACNA1D—epilepsy syndrome	0.000209	0.0206	CrCbGaD
Diphenylpyraline—Cinnarizine—CACNA1H—epilepsy syndrome	0.000202	0.0199	CrCbGaD
Diphenylpyraline—Mepenzolate—CHRM3—epilepsy syndrome	0.000194	0.0191	CrCbGaD
Diphenylpyraline—Cinnarizine—CACNA1D—epilepsy syndrome	0.00019	0.0188	CrCbGaD
Diphenylpyraline—Mepenzolate—CHRM1—epilepsy syndrome	0.000181	0.0178	CrCbGaD
Diphenylpyraline—Trospium—CHRM2—epilepsy syndrome	0.000177	0.0174	CrCbGaD
Diphenylpyraline—Diphenidol—CHRM3—epilepsy syndrome	0.00017	0.0167	CrCbGaD
Diphenylpyraline—Orphenadrine—SCN9A—epilepsy syndrome	0.000162	0.016	CrCbGaD
Diphenylpyraline—Metixene—CHRM3—epilepsy syndrome	0.000162	0.016	CrCbGaD
Diphenylpyraline—Diphenidol—CHRM1—epilepsy syndrome	0.000159	0.0156	CrCbGaD
Diphenylpyraline—Metixene—CHRM1—epilepsy syndrome	0.000151	0.0149	CrCbGaD
Diphenylpyraline—Orphenadrine—SCN4A—epilepsy syndrome	0.000149	0.0147	CrCbGaD
Diphenylpyraline—Mepenzolate—CHRM2—epilepsy syndrome	0.000148	0.0146	CrCbGaD
Diphenylpyraline—Trimethaphan—BCHE—epilepsy syndrome	0.000148	0.0145	CrCbGaD
Diphenylpyraline—Benzatropine—CHRM1—epilepsy syndrome	0.00014	0.0138	CrCbGaD
Diphenylpyraline—Diphenidol—CHRM2—epilepsy syndrome	0.000129	0.0128	CrCbGaD
Diphenylpyraline—Fentanyl—OPRD1—epilepsy syndrome	0.000127	0.0126	CrCbGaD
Diphenylpyraline—Metixene—CHRM2—epilepsy syndrome	0.000124	0.0122	CrCbGaD
Diphenylpyraline—Cyproheptadine—CHRM3—epilepsy syndrome	0.000123	0.0121	CrCbGaD
Diphenylpyraline—Reboxetine—SLC6A4—epilepsy syndrome	0.000117	0.0116	CrCbGaD
Diphenylpyraline—Cyproheptadine—CHRM1—epilepsy syndrome	0.000115	0.0113	CrCbGaD
Diphenylpyraline—Benzatropine—CHRM2—epilepsy syndrome	0.000114	0.0112	CrCbGaD
Diphenylpyraline—Orphenadrine—SCN1A—epilepsy syndrome	0.000109	0.0107	CrCbGaD
Diphenylpyraline—Fentanyl—OPRM1—epilepsy syndrome	9.75e-05	0.00961	CrCbGaD
Diphenylpyraline—Cyproheptadine—CHRM2—epilepsy syndrome	9.36e-05	0.00922	CrCbGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	8.6e-05	0.000919	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	8.44e-05	0.000902	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	8.43e-05	0.000901	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	8.4e-05	0.000898	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	8.4e-05	0.000898	CbGpPWpGaD
Diphenylpyraline—Reboxetine—CYP2D6—epilepsy syndrome	8.25e-05	0.00812	CrCbGaD
Diphenylpyraline—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	8.24e-05	0.000881	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	8.24e-05	0.000881	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	8.22e-05	0.000878	CbGpPWpGaD
Diphenylpyraline—Trospium—CYP2D6—epilepsy syndrome	8.1e-05	0.00797	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	8.09e-05	0.000865	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	8.07e-05	0.000863	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	8e-05	0.000855	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	7.97e-05	0.000851	CbGpPWpGaD
Diphenylpyraline—Bifonazole—CYP2C19—epilepsy syndrome	7.93e-05	0.00781	CrCbGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	7.9e-05	0.000845	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	7.9e-05	0.000844	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	7.9e-05	0.000844	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	7.75e-05	0.000828	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	7.61e-05	0.000813	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	7.59e-05	0.000811	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	7.56e-05	0.000808	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	7.52e-05	0.000804	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	7.39e-05	0.000789	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	7.33e-05	0.000783	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	7.2e-05	0.000769	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	7.15e-05	0.000764	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	7.07e-05	0.000756	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	7.07e-05	0.000756	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	7.07e-05	0.000756	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	7.07e-05	0.000756	CbGpPWpGaD
Diphenylpyraline—Mianserin—HTR7—epilepsy syndrome	7.06e-05	0.00696	CrCbGaD
Diphenylpyraline—Benzatropine—CYP2C19—epilepsy syndrome	7.04e-05	0.00693	CrCbGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	6.92e-05	0.000739	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	6.91e-05	0.000738	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	6.88e-05	0.000735	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	6.79e-05	0.000725	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	6.6e-05	0.000705	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	6.6e-05	0.000705	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	6.6e-05	0.000705	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	6.6e-05	0.000705	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	6.6e-05	0.000705	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	6.47e-05	0.000691	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	6.47e-05	0.000691	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—PRKCB—epilepsy syndrome	6.46e-05	0.00069	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	6.4e-05	0.000684	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—SST—epilepsy syndrome	6.4e-05	0.000684	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	6.37e-05	0.00068	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	6.35e-05	0.000679	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	6.32e-05	0.000675	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	6.26e-05	0.000669	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	6.25e-05	0.000668	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	6.25e-05	0.000667	CbGpPWpGaD
Diphenylpyraline—Benzphetamine—ADRA2A—epilepsy syndrome	6.25e-05	0.00615	CrCbGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	6.18e-05	0.000661	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	6.16e-05	0.000658	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	6.16e-05	0.000658	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	6.13e-05	0.000655	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.12e-05	0.000654	CbGpPWpGaD
Diphenylpyraline—Mianserin—ADRA2A—epilepsy syndrome	6.06e-05	0.00596	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	6.01e-05	0.000643	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	6.01e-05	0.000643	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	5.99e-05	0.00064	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	5.99e-05	0.00064	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	5.99e-05	0.00064	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	5.99e-05	0.00064	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	5.99e-05	0.00064	CbGpPWpGaD
Diphenylpyraline—Phenoxybenzamine—ADRA2A—epilepsy syndrome	5.97e-05	0.00588	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	5.9e-05	0.000631	CbGpPWpGaD
Diphenylpyraline—Reboxetine—ABCB1—epilepsy syndrome	5.89e-05	0.0058	CrCbGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	5.87e-05	0.000628	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	5.87e-05	0.000628	CbGpPWpGaD
Diphenylpyraline—Diphenhydramine—CHRM2—epilepsy syndrome	5.86e-05	0.00577	CrCbGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	5.85e-05	0.000625	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.84e-05	0.000624	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	5.77e-05	0.000616	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	5.76e-05	0.000615	CbGpPWpGaD
Diphenylpyraline—SLC6A3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	5.67e-05	0.000606	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	5.61e-05	0.000599	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	5.61e-05	0.000599	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	5.61e-05	0.000599	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	5.61e-05	0.000599	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	5.57e-05	0.000595	CbGpPWpGaD
Diphenylpyraline—Orphenadrine—CHRM2—epilepsy syndrome	5.55e-05	0.00546	CrCbGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	5.41e-05	0.000578	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	5.39e-05	0.000576	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	5.31e-05	0.000568	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	5.31e-05	0.000568	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	5.3e-05	0.000566	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	5.27e-05	0.000564	CbGpPWpGaD
Diphenylpyraline—Benzatropine—CYP2D6—epilepsy syndrome	5.22e-05	0.00514	CrCbGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	5.21e-05	0.000557	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	5.21e-05	0.000557	CbGpPWpGaD
Diphenylpyraline—Modafinil—CYP2C19—epilepsy syndrome	5.21e-05	0.00513	CrCbGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	5.09e-05	0.000544	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	5.09e-05	0.000544	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	5.09e-05	0.000544	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	5.09e-05	0.000544	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	5.03e-05	0.000537	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	4.9e-05	0.000524	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	4.9e-05	0.000524	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	4.87e-05	0.000521	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	4.87e-05	0.000521	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	4.85e-05	0.000518	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.8e-05	0.000513	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	4.79e-05	0.000512	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	4.77e-05	0.00051	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.76e-05	0.000509	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	4.74e-05	0.000506	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	4.74e-05	0.000506	CbGpPWpGaD
Diphenylpyraline—Atomoxetine—SLC6A4—epilepsy syndrome	4.73e-05	0.00466	CrCbGaD
Diphenylpyraline—Cyproheptadine—HTR2A—epilepsy syndrome	4.68e-05	0.00461	CrCbGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	4.67e-05	0.000499	CbGpPWpGaD
Diphenylpyraline—Mianserin—SLC6A4—epilepsy syndrome	4.62e-05	0.00455	CrCbGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.61e-05	0.000493	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	4.57e-05	0.000489	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	4.54e-05	0.000485	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	4.5e-05	0.000481	CbGpPWpGaD
Diphenylpyraline—Atomoxetine—CYP2C19—epilepsy syndrome	4.48e-05	0.00441	CrCbGaD
Diphenylpyraline—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	4.45e-05	0.000476	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	4.45e-05	0.000476	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	4.45e-05	0.000476	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	4.33e-05	0.000463	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	4.25e-05	0.000454	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.23e-05	0.000452	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	4.15e-05	0.000444	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	4.14e-05	0.000443	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	4.14e-05	0.000442	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	4.12e-05	0.00044	CbGpPWpGaD
Diphenylpyraline—Bepridil—CYP2D6—epilepsy syndrome	4.11e-05	0.00405	CrCbGaD
Diphenylpyraline—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	4.09e-05	0.000437	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	4.08e-05	0.000436	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	4.03e-05	0.000431	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	4e-05	0.000427	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	4e-05	0.000427	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	4e-05	0.000427	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	3.86e-05	0.000413	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	3.83e-05	0.000409	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	3.76e-05	0.000402	CbGpPWpGaD
Diphenylpyraline—Cinnarizine—CYP2D6—epilepsy syndrome	3.74e-05	0.00368	CrCbGaD
Diphenylpyraline—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	3.69e-05	0.000394	CbGpPWpGaD
Diphenylpyraline—Atomoxetine—HTR2A—epilepsy syndrome	3.63e-05	0.00358	CrCbGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	3.63e-05	0.000388	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	3.63e-05	0.000388	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	3.63e-05	0.000388	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	3.63e-05	0.000388	CbGpPWpGaD
Diphenylpyraline—Diphenhydramine—CYP2C19—epilepsy syndrome	3.62e-05	0.00356	CrCbGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	3.61e-05	0.000386	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	3.61e-05	0.000386	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.61e-05	0.000386	CbGpPWpGaD
Diphenylpyraline—Mianserin—HTR2A—epilepsy syndrome	3.55e-05	0.0035	CrCbGaD
Diphenylpyraline—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.54e-05	0.000378	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	3.54e-05	0.000378	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	3.54e-05	0.000378	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	3.54e-05	0.000378	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	3.54e-05	0.000378	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.54e-05	0.000378	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	3.47e-05	0.000371	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	3.47e-05	0.000371	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	3.41e-05	0.000364	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	3.41e-05	0.000364	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.4e-05	0.000363	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.4e-05	0.000363	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.34e-05	0.000356	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.32e-05	0.000355	CbGpPWpGaD
Diphenylpyraline—Atomoxetine—CYP2D6—epilepsy syndrome	3.32e-05	0.00327	CrCbGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	3.29e-05	0.000352	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PGF—epilepsy syndrome	3.29e-05	0.000352	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	3.28e-05	0.000351	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—SST—epilepsy syndrome	3.28e-05	0.000351	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.25e-05	0.000348	CbGpPWpGaD
Diphenylpyraline—Mianserin—CYP2D6—epilepsy syndrome	3.25e-05	0.0032	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	3.22e-05	0.000344	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.21e-05	0.000343	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	3.15e-05	0.000337	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	3.14e-05	0.000335	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	3.14e-05	0.000335	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.1e-05	0.000331	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.09e-05	0.00033	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.09e-05	0.00033	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	3.03e-05	0.000324	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	3.02e-05	0.000323	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	3.01e-05	0.000322	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	3.01e-05	0.000322	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	3.01e-05	0.000322	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	3.01e-05	0.000322	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	2.96e-05	0.000316	CbGpPWpGaD
Diphenylpyraline—Bepridil—ABCB1—epilepsy syndrome	2.93e-05	0.00289	CrCbGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.88e-05	0.000308	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.87e-05	0.000307	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.83e-05	0.000302	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GAL—epilepsy syndrome	2.83e-05	0.000302	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	2.83e-05	0.000302	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	2.82e-05	0.000301	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	2.8e-05	0.000299	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	2.8e-05	0.000299	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	2.8e-05	0.000299	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	2.74e-05	0.000293	CbGpPWpGaD
Diphenylpyraline—Fentanyl—ABCB1—epilepsy syndrome	2.7e-05	0.00266	CrCbGaD
Diphenylpyraline—Diphenhydramine—CYP2D6—epilepsy syndrome	2.68e-05	0.00264	CrCbGaD
Diphenylpyraline—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.68e-05	0.000287	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.63e-05	0.000281	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.63e-05	0.000281	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	2.63e-05	0.000281	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	2.57e-05	0.000275	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	2.56e-05	0.000273	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	2.49e-05	0.000266	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	2.45e-05	0.000262	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	2.41e-05	0.000258	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.33e-05	0.000249	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	2.28e-05	0.000244	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.28e-05	0.000244	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NPY—epilepsy syndrome	2.22e-05	0.000237	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.22e-05	0.000237	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	2.16e-05	0.000231	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CRH—epilepsy syndrome	2.14e-05	0.000229	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	2.14e-05	0.000229	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	2.14e-05	0.000229	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—OXT—epilepsy syndrome	2.14e-05	0.000229	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	2.14e-05	0.000229	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	2.12e-05	0.000226	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.07e-05	0.000221	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2e-05	0.000214	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	1.99e-05	0.000213	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	1.99e-05	0.000213	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	1.96e-05	0.00021	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SST—epilepsy syndrome	1.94e-05	0.000207	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	1.94e-05	0.000207	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	1.94e-05	0.000207	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.92e-05	0.000205	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.9e-05	0.000203	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.89e-05	0.000202	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	1.82e-05	0.000195	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.82e-05	0.000195	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	1.82e-05	0.000195	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.81e-05	0.000194	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.81e-05	0.000193	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	1.79e-05	0.000191	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	1.79e-05	0.000191	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	1.78e-05	0.000191	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	1.75e-05	0.000187	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	1.69e-05	0.000181	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	1.66e-05	0.000178	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	1.65e-05	0.000177	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.62e-05	0.000174	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.62e-05	0.000173	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.54e-05	0.000164	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.52e-05	0.000163	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.52e-05	0.000162	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.47e-05	0.000157	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.39e-05	0.000149	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.35e-05	0.000144	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.35e-05	0.000144	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.34e-05	0.000144	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.3e-05	0.000139	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.28e-05	0.000137	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.25e-05	0.000134	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.22e-05	0.000131	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.16e-05	0.000124	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.16e-05	0.000124	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.14e-05	0.000121	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.11e-05	0.000119	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.07e-05	0.000115	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.07e-05	0.000114	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—POMC—epilepsy syndrome	9.77e-06	0.000104	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	9.55e-06	0.000102	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	8.64e-06	9.23e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RELA—epilepsy syndrome	8.02e-06	8.57e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	7.86e-06	8.4e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.3e-06	7.8e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	7.23e-06	7.73e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—JUN—epilepsy syndrome	7.02e-06	7.51e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	6.83e-06	7.3e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	6.63e-06	7.08e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SRC—epilepsy syndrome	6.3e-06	6.73e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	6.14e-06	6.56e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	3.91e-06	4.18e-05	CbGpPWpGaD
